Regencell Bioscience Holdings Ltd (RGC) — Capital Reinvestment Ratio
Regencell Bioscience Holdings Ltd (RGC) has a Capital Reinvestment Ratio of 0.49x as of December 2017, meaning it reinvests 0% of its operating cash flow ($154.30 Million) in capital expenditures ($74.90 Million). Check Regencell Bioscience Holdings Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Regencell Bioscience Holdings Ltd Capital Reinvestment Ratio (2010–2018)
This chart tracks Regencell Bioscience Holdings Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Regencell Bioscience Holdings Ltd (RGC) cash conversion ratio.
Annual Capital Reinvestment Ratio for Regencell Bioscience Holdings Ltd (2010–2018)
Year-by-year Capital Reinvestment Ratio for Regencell Bioscience Holdings Ltd from 2010 to 2018. See Regencell Bioscience Holdings Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.61x | $409.90 Million | $250.40 Million | ▲ +16.7% |
| 2017 | 0.52x | $410.50 Million | $214.90 Million | ▲ +22.5% |
| 2016 | 0.43x | $434.40 Million | $185.70 Million | ▼ -4.8% |
| 2015 | 0.45x | $349.10 Million | $156.80 Million | ▲ +39.0% |
| 2014 | 0.32x | $346.90 Million | $112.10 Million | ▲ +25.6% |
| 2013 | 0.26x | $346.60 Million | $89.20 Million | ▲ +4.2% |
| 2012 | 0.25x | $353.10 Million | $87.20 Million | ▼ -34.9% |
| 2011 | 0.38x | $259.40 Million | $98.40 Million | ▲ +43.2% |
| 2010 | 0.26x | $410.80 Million | $108.80 Million | — |